Join
Live feed
·
INSIDERFilingvia Quantisnow
Acumen Pharmaceuticals Inc. logo

Chief Regulatory Officer Schacterle Amy sold $2,176 worth of shares (1,097 units at $1.98), decreasing direct ownership by 12% to 7,703 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ABOS· Acumen Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABOS (Acumen Pharmaceuticals Inc.) and more on Quantisnow.